Press Releases Shanghai Pharmaceuticals Holding Co., Ltd Other OTC

Equities

SHPMY

US81943R1005

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shionogi & Co., Ltd. - Notice Regarding a License Agreement for Promotion of Ensitrelvir Fumaric Acid, a Therapeutic Drug for COVID-19, in China	22-12-30	AQ
Shanghai Pharmaceuticals : REPLY SLIP FOR HOLDERS OF H SHARE ATTENDING THE EXTRAORDINARY GENERAL MEETING	21-07-26	PU
Shanghai Pharmaceuticals : The Fortune 500 company Shanghai Pharmaceuticals enters the dental equipment market by acquiring Finnish dental equipment company Fimet Oy and its operations in Finland and China	21-07-06	AQ
Shanghai Pharmaceuticals : CONNECTED TRANSACTION PROPOSED NON-PUBLIC ISSUANCE OF A SHARES	21-05-12	PU
Shanghai Pharmaceuticals : SUPPLEMENT ANNOUNCEMENT TO THE 2019 SHARE OPTION INCENTIVE SCHEME OF THE COMPANY	20-08-21	PU
Enzymatica publ : signs agreement with Keyuan Trade for China	20-01-22	AQ
Shanghai Pharmaceuticals : GRANT OF SHARE OPTIONS UNDER THE SHARE OPTION SCHEME	19-12-19	PU
Shanghai Pharmaceuticals : RESULTS OF THE EXTRAORDINARY GENERAL MEETING, A SHARE CLASS MEETING, AND H SHARE CLASS MEETING	19-12-18	PU
Shanghai Pharmaceuticals : Notification Letter and Change Request Form to Registered Shareholder	19-10-31	PU
Shanghai Pharmaceuticals : REPLY SLIP FOR HOLDERS OF H SHARE ATTENDING THE 2019 SECOND H SHARE CLASS MEETING	19-10-31	PU
Shanghai Pharmaceuticals : FORM OF PROXY OF HOLDERS OF H SHARES FOR USE AT THE 2019 SECOND H SHARE CLASS MEETING	19-10-31	PU
Shanghai Pharmaceuticals : PROXY FORM OF THE INDEPENDENT NON-EXECUTIVE DIRECTOR FOR USE AT THE 2019 SECOND H SHARE CLASS MEETING	19-10-31	PU
Shanghai Pharmaceuticals : NOTICE OF 2019 SECOND H SHARE CLASS MEETING	19-10-31	PU
Shanghai Pharmaceuticals : REPLY SLIP FOR HOLDERS OF H SHARE ATTENDING THE 2019 FIRST EXTRAORDINARY GENERAL MEETING	19-10-31	PU
Shanghai Pharmaceuticals : PROXY FORM OF HOLDERS OF H SHARES FOR USE AT THE 2019 FIRST EXTRAORDINARY GENERAL MEETING	19-10-31	PU
Shanghai Pharmaceuticals : PROXY FORM OF THE INDEPENDENT NON-EXECUTIVE DIRECTOR FOR USE AT THE 2019 FIRST EXTRAORDINARY GENERAL MEETING	19-10-31	PU
Shanghai Pharmaceuticals : Proposed Adoption of the 2019 Share Option Scheme Assessment Management Measures for the Implementation of the 2019 Share Option Scheme and Proposed Authorization to the Board to Deal with Relevant Matters in Relation to the 2019 Share Option Scheme	19-10-31	PU
Shanghai Pharmaceuticals : PROPOSED ADOPTION OF THE SHARE OPTION SCHEME AND THE GRANT THEREUNDER	19-09-30	PU
Shanghai Pharmaceuticals : CSRC'S APPROVAL ON ISSUANCE OF NEW H SHARES	19-09-20	PU
Shanghai Pharmaceuticals : Notification Letter and Change Request Form to Registered Shareholder	19-09-16	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Shanghai Pharmaceuticals Holding Co., Ltd Other OTC

Equities

SHPMY

US81943R1005

Press Releases

Filters